EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations



Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations



Journal of Veterinary Pharmacology and Therapeutics 24(4): 247-250



Two commercially available long-acting oxytetracycline (OTC) formulations were administered by the intramuscular (i.m.) route to six healthy pigs at the recommended dose of 30 mg/kg. After 2 h the mean maximum concentration (Cmax) reached values of 8.1 +/- 2.2 and 15.4 +/- 11.1 microgram/mL, respectively. These concentrations remained higher than 0.5 microgram/mL for more than 5 days after drug administration. The area under the concentration time curve (AUC(0-9 days)) of each formulation was 255 +/- 76.5 and 399.2 +/- 123 microgram(.)h/mL, respectively, and the mean residence time (MRT) was around 3 days for both formulations. No significant differences were observed between the pharmacokinetic parameters of the two formulations, showing the bioequivalence of the two formulations studied according to the criteria established by the Food and Drug Administration (FDA) and the Committee for Veterinary Medicinal Products (CVMP).

Accession: 003408552

Download citation: RISBibTeXText

PMID: 11555179

DOI: 10.1046/j.1365-2885.2001.00342.x

Download PDF Full Text: Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations



Related references

Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines. Frontiers in Veterinary Science 3: 50-50, 2016

Pharmacokinetics of Short- and Long-acting Formulations of Oxytetracycline After Intramuscular Administration in Chickens. Journal of Avian Medicine and Surgery 29(4): 298-302, 2016

Bioequivalence study of two long-acting formulations of oxytetracycline following intramuscular administration in the sheep. Revue de Medecine Veterinaire 151(3): 213-216, 2000

Tissue reaction and residues in slaughter cattle after administration of long acting oxytetracycline formulations. Journal of the South African Veterinary Association 55(3): 107-111, 1984

Long acting injectable oxytetracycline-liposphere formulations. International Journal Of Pharmaceutics (amsterdam). 124(2): 271-278, 1995

Plasma bioavailability of 2 long-acting oxytetracycline formulations in the pig. Veterinary Research 25(4): 399-404, 1994

Disposition kinetics of oxytetracycline-long acting in buffalo calves. 2005

Pharmacokinetics of long acting and conventional formulations of oxytetracycline in goats. Indian Veterinary Journal 82(7): 724-727, 2005

Comparative plasma bioavailability of two long-acting 20% oxytetracycline formulations. Revue de Medecine Veterinaire 139(5): 513-519, 1988

Bioequivalence study of two long-acting oxytetracycline formulations in sheep. Veterinary Research Communications 30(8): 929-934, 2006

Disposition kinetics of long acting oxytetracycline in cows suffering from brucellosis. Indian Veterinary Journal 82(3): 260-263, 2005

Disposition kinetics and bioavailability of long-acting oxytetracycline in afebrile and febrile dog. Indian Journal of Animal Sciences 64(5): 455-459, 1994

Comparison of the pharmacokinetics of conventional and long-acting formulations of oxytetracycline in sheep. Turk Veterinerlik ve Hayvanclk Dergisi 25(2): 173-177, 2001